{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:49Z","timestamp":1792783429424,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"publisher","award":["No. 02"],"award-info":[{"award-number":["No. 02"]}],"id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/04zb31v77","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Saitama Medical University","id":[{"id":"https:\/\/ror.org\/04zb31v77","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary central nervous system lymphoma (PCNSL) is a rare extranodal lymphoma, with diffuse large B cell lymphoma accounting for most cases. T cell variants are uncommon and associated with poor outcomes. We report a case of primary CNS T cell lymphoma with simultaneous brain and spinal cord involvement. A 37-year-old Japanese man presented with impaired consciousness, and brain magnetic resonance imaging revealed multiple contrast-enhancing parenchymal lesions. Histopathological examination of a brain biopsy specimen demonstrated medium- to large-sized atypical lymphoid cells, leading to a diagnosis of peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). Comprehensive systemic evaluation showed no extracranial disease; however, contrast-enhanced spinal magnetic resonance imaging revealed extensive lesions from the cervical spinal cord to the thoracic spinal cord. Next-generation sequencing analysis identified a mutation in SETD2, possibly contributing to the aggressive disease behavior. The patient received methotrexate, procarbazine, and vincristine as first-line therapy and achieved an initial radiological complete response. However, rapid disease relapse occurred with newly developed lesions in the pineal gland and cranial nerves, and the patient died shortly after initiation of consolidation therapy. This case highlights the aggressive clinical course of primary CNS T cell lymphoma with spinal cord involvement and underscores the importance of molecular genetic profiling in this rare entity.<\/jats:p>","DOI":"10.1007\/s12185-026-04262-7","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:54:08Z","timestamp":1785840848000},"page":"594-598","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary central nervous system T cell lymphoma involving multiple brain and spinal cord lesions with SETD2 mutation"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0202-1466","authenticated-orcid":false,"given":"Ken","family":"Naganuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Imada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Tabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"4262_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ajcp\/110.5.607","volume":"110","author":"S Camilleri-Bro\u00ebt","year":"1998","unstructured":"Camilleri-Bro\u00ebt S, Martin A, Moreau A, Angonin R, H\u00e9nin D, Gontier MF, et al. Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d\u2019\u00e9tude des Leuc\u00e9nies et Autres Maladies du Sang (GOELAMS). Am J Clin Pathol. 1998;110:607\u201312.","journal-title":"Am J Clin Pathol"},{"key":"4262_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","volume":"21","author":"AJ Ferreri","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003;21:266\u201372.","journal-title":"J Clin Oncol"},{"key":"4262_CR3","doi-asserted-by":"publisher","first-page":"28897","DOI":"10.18632\/oncotarget.25622","volume":"9","author":"D Chihara","year":"2018","unstructured":"Chihara D, Fowler NH, Oki Y, Fanale MA, Nastoupil LJ, Westin JR, et al. Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis. Oncotarget. 2018;9:28897\u2013902.","journal-title":"Oncotarget"},{"key":"4262_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1200\/JCO.2005.07.109","volume":"23","author":"TN Shenkier","year":"2005","unstructured":"Shenkier TN, Blay JY, O\u2019Neill BP, Poortmans P, Thiel E, Jahnke K, et al. Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol. 2005;23:2233\u20139.","journal-title":"J Clin Oncol"},{"key":"4262_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/jamaneurol.2013.606","volume":"70","author":"BJ Scott","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013;70:311\u20139.","journal-title":"JAMA Neurol"},{"key":"4262_CR6","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1111\/cas.70111","volume":"116","author":"T Takahashi","year":"2025","unstructured":"Takahashi T, Sawada K, Yamashita T, Yamamoto W, Iijima Y, Adachi A, et al. Genetic profiling reveals the distinctions among MTX-associated DLBCL, EBV-positive Mucocutaneous Ulcer, and EBV + DLBCL. Cancer Sci. 2025;116:2306\u201316.","journal-title":"Cancer Sci"},{"key":"4262_CR7","doi-asserted-by":"crossref","unstructured":"Ito K, Imada H, Nagata M, Yamashita T, Sawada K, Takahashi T, et al. Significance and Utility of Immunohistochemical MTAP Expression to Predict CDKN2A Genomic Status in Diffuse Large B-Cell Lymphoma. Pathol Int. 2025.","DOI":"10.1111\/pin.70072"},{"key":"4262_CR8","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ van Dongen","year":"2003","unstructured":"van Dongen JJ, Langerak AW, Br\u00fcggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257\u2013317.","journal-title":"Leukemia"},{"key":"4262_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/blood.2020008377","volume":"140","author":"LR Schaff","year":"2022","unstructured":"Schaff LR, Grommes C. Primary central nervous system lymphoma. Blood. 2022;140:971\u20139.","journal-title":"Blood"},{"key":"4262_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1309\/LM85GPXDT8NJSDAB","volume":"46","author":"M Guzzetta","year":"2015","unstructured":"Guzzetta M, Drexler S, Buonocore B, Donovan V. Primary CNS T-cell lymphoma of the spinal cord: case report and literature review. Lab Med. 2015;46:159\u201363.","journal-title":"Lab Med"},{"key":"4262_CR11","first-page":"149","volume":"21","author":"DK Lee","year":"2002","unstructured":"Lee DK, Chung CK, Kim HJ, Kim K, Choe G, Moon CW, et al. Multifocal primary CNS T cell lymphoma of the spinal cord. Clin Neuropathol. 2002;21:149\u201355.","journal-title":"Clin Neuropathol"},{"key":"4262_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11060-008-9633-2","volume":"90","author":"N Levin","year":"2008","unstructured":"Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol. 2008;90:77\u201383.","journal-title":"J Neurooncol"},{"key":"4262_CR13","first-page":"2477","volume":"56","author":"Y Hiroshima","year":"2015","unstructured":"Hiroshima Y, Kaiume H, Kirihara T, Takeda W, Kurihara T, Sato K, et al. Successful long-term control of recurrent primary central nervous system anaplastic large cell lymphoma after autologous hematopoietic stem cell transplantation with concurrent whole brain and spinal cord radiotherapy. Rinsho Ketsueki. 2015;56:2477\u201382.","journal-title":"Rinsho Ketsueki"},{"key":"4262_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1212\/WNL.0b013e31822b00b9","volume":"77","author":"EP Flanagan","year":"2011","unstructured":"Flanagan EP, O\u2019Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology. 2011;77:784\u201391.","journal-title":"Neurology"},{"key":"4262_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijrobp.2005.07.958","volume":"64","author":"PC O'Brien","year":"2006","unstructured":"O\u2019Brien PC, Roos DE, Pratt G, Liew KH, Barton MB, Poulsen MG, et al. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Biol Phys. 2006;64:408\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4262_CR16","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","volume":"31","author":"PG Morris","year":"2013","unstructured":"Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, et al. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol. 2013;31:3971\u20139.","journal-title":"J Clin Oncol"},{"key":"4262_CR17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/PAS.0000000000000503","volume":"39","author":"MP Menon","year":"2015","unstructured":"Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, et al. Primary CNS T-cell lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis. Am J Surg Pathol. 2015;39:1719\u201329.","journal-title":"Am J Surg Pathol"},{"key":"4262_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/PAS.0000000000001859","volume":"46","author":"J Yim","year":"2022","unstructured":"Yim J, Koh J, Kim S, Song SG, Bae JM, Yun H, et al. Clinicopathologic and genetic features of primary T-cell lymphomas of the central nervous system: an analysis of 11 cases using targeted gene sequencing. Am J Surg Pathol. 2022;46:486\u201397.","journal-title":"Am J Surg Pathol"},{"key":"4262_CR19","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1038\/ncomms12602","volume":"7","author":"A Roberti","year":"2016","unstructured":"Roberti A, Dobay MP, Bisig B, Vallois D, Bo\u00e9chat C, Lanitis E, et al. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun. 2016;7:12602.","journal-title":"Nat Commun"},{"key":"4262_CR20","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20160894","volume":"214","author":"AB Moffitt","year":"2017","unstructured":"Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, et al. Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med. 2017;214:1371\u201386.","journal-title":"J Exp Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04262-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04262-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:59:25Z","timestamp":1791194365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04262-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4262"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04262-7","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TT has received honoraria from Chugai Pharma, AbbVie, Nippon Shinyaku, and Janssen Pharma. Other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained by authors from patients prior to submission of the case report.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}